ArticlebioRxiv : the preprint server for biology2025
Unraveling systemic responses to NQO1-activated IB-DNQ and Rucaparib single and dual agent therapy in triple-negative breast cancers.
Avery M Runnebohm et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.